Emphysema (폐기종)English Version1. DefinitionEmphysema is a chronic lung disease and one of the two main types of COPD (Chronic Obstructive Pulmonary Disease).It is characterized by destruction of the alveoli (air sacs), causing loss of lung elasticity and air trapping, which makes it difficult to exhale.As the alveoli walls break down, the lung becomes overinflated, reducing surface area for gas..

What is Ataxia? / 운동실조증이란?English:Ataxia is a neurological condition characterized by lack of muscle coordination during voluntary movements such as walking, speaking, or swallowing. It is not a disease itself but a symptom of damage to the part of the brain that controls coordination—typically the cerebellum, or sometimes the spinal cord or peripheral nerves.Korean (한국어):운동실조증은 의도적인 움직임에서 근육 조절..

Classification | 분류Therapeutic Class | 치료 분류: Antidiabetic agent (당뇨병 치료제)Pharmacologic Class | 약리 분류: Sulfonylurea (설포닐우레아 계열)Indications | 적응증Management of type 2 diabetes mellitus when diet and exercise alone are insufficient식이요법과 운동만으로 조절이 어려운 제2형 당뇨병 관리Therapeutic Effects | 치료 효과Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells췌장 베타 세포에서 인슐린 분비 촉진을 통해 혈당 ..

Classification | 분류Therapeutic Class | 치료 분류: Iron supplement (철분 보충제)Pharmacologic Class | 약리 분류: Mineral supplement (미네랄 보충제)Indications | 적응증Treatment and prevention of iron deficiency anemia철 결핍성 빈혈 치료 및 예방Therapeutic Effects | 치료 효과Increases serum iron levels혈중 철분 농도 증가Improves symptoms related to iron deficiency such as fatigue and pallor피로 및 창백과 같은 철 결핍 관련 증상 개선Absorption | 흡수Absorbed pri..

Nursing Medication Card – Ramipril약물명 (Drug Name): Ramipril (라미프릴)상품명 (Brand Name): Altace (알타제)약물분류 (Class): Antihypertensive / ACE Inhibitor (혈압강하제 / 안지오텐신 전환효소 억제제)1. Indications (적응증)Hypertension (고혈압)Heart failure post-myocardial infarction (심근경색 후 심부전)Risk reduction of myocardial infarction, stroke, and death in high-risk patients(고위험 환자의 심근경색, 뇌졸중, 심혈관 사망 위험 감소)2. Therapeutic Effects (치료 ..

로수바스타틴 (Rosuvastatin, 크레스토)분류: 지질강하제 / HMG-CoA 환원효소 억제제 (스타틴 계열)1. 적응증 (Indications)고지혈증 (고콜레스테롤혈증)고중성지방혈증혼합형 이상지질혈증심혈관 질환 고위험군의 예방가족성 고콜레스테롤혈증 (호모접합형)2. 치료 효과 (Therapeutic Effects)콜레스테롤 생합성에 필요한 HMG-CoA 환원효소 억제LDL(나쁜 콜레스테롤), 총 콜레스테롤, 중성지방 감소HDL(좋은 콜레스테롤) 증가죽상동맥경화증의 진행 지연3. 흡수 (Absorption)생체이용률: 약 20%최고혈중농도 도달: 복용 후 3~5시간음식 섭취와 큰 영향 없음4. 분포 (Distribution)혈장 단백 결합률: 약 88%뇌혈관장벽 통과 거의 없음모유로의 이행 거의 ..